Viewing Study NCT00003351


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-02-02 @ 9:42 AM
Study NCT ID: NCT00003351
Status: COMPLETED
Last Update Posted: 2016-07-14
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV breast cancer View